Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

NCT00899353 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Original Principal Investigator left the institution.

Conditions

Monoclonal Gammopathy of Undetermined Significance
Smoldering Multiple Myeloma
Chronic Lymphocytic Leukemia

Interventions

DIETARY_SUPPLEMENT: Omega 3 Fatty Acid

Sponsor

Marshall University

Collaborators

[object Object]